Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment
di: Taylor C. Duke, MD, Ranjit Nair, MD, Carlos Torres-Cabala, MD, Rodabe N. Amaria, MD, Elizabeth Keiser, MD, Roberto Miranda, MD, Swaminathan P. Iyer, MD, Meghan Heberton, MD
| Natura: | Article |
|---|---|
| Pubblicazione: | Elsevier 2020-12-01 |
Descrizione
Soggetti
angioimmunoblastic T-cell lymphoma; immune checkpoint therapy; metastatic melanoma; pembrolizumab; programmed death-1